Come up with a name for your new list and we'll add to it:
Envisagenics raised a round of funding on May 22, 2018. Investors include
National Institutes of Health.
Envisagenics is a life science company that applies artificial intelligence to the genetic sequence of patients to discover new therapies. The company's proprietary cloud-based discovery platform, Spl…